Vale Base Metals Releases 2025 Exploration and 2026 Outlook Results; Copper Mineral Reserves and Mineral Resources Increase 6% to 53 million tonnes
Link to PDF TORONTO, March 31, 2026 /PRNewswire/ -- Vale Base Metals (VBM) is on track to increase its total Mineral Reserves and Resources in Canada and Brazil by more than 20 per cent by the end of 2027, according to new engineering and...
Clarity signs a large-scale Manufacturing Supply Agreement for copper-64 with Theragenics
SYDNEY, March 25, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with...
Gansu advances industrial upgrade to bolster growth
BEIJING, March 9, 2026 /PRNewswire/ -- A news report from chinadaily.com.cn： Northwest China's Gansu province is transforming its industrial base by pushing forward an industry-driven development strategy to modernize its economic structure and...
Kinterra Capital Closes Oversubscribed US$950 Million Fund II Following Strong Investor Demand
TORONTO, Feb. 18, 2026 /PRNewswire/ -- Kinterra Capital Corp. ("Kinterra" or the "Firm"), a leading private equity firm investing in critical materials and the associated infrastructure essential to the modern economy, today announced the successful...
Registration Opens for the 21st ALUMINIUM CHINA: Driving the Non-Ferrous Metals Industry into a New Era
SHANGHAI, Feb. 10, 2026 /PRNewswire/ -- Visitor registration has officially opened for the 21st ALUMINIUM CHINA, one of Asia's leading trade events for the non-ferrous metals industry, scheduled for July 8–10, 2026, at the Shanghai New International...
Proposed acquisition by US-backed Orion Critical Mineral Consortium of a strategic stake in Glencore's DRC assets
WASHINGTON, Feb. 3, 2026 /PRNewswire/ -- Glencore and the Orion Critical Mineral Consortium ("Orion CMC") announce that they have entered into a non-binding Memorandum of Understanding in relation to a potential acquisition by Orion CMC of a 40%...
Clarity signs copper-67 Supply Agreement with Nusano
SYDNEY, Oct. 16, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with...
Clarity enters a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with SpectronRx
Highlights Clarity has entered into a Commercial Manufacturing Agreement with SpectronRx for 64Cu-SAR-bisPSMA. SpectronRx's facility in Indiana will provide on-demand commercial-scale manufacturing of both copper-64 and 64Cu-SAR-bisPSMA under one...
First patient imaged in Phase III AMPLIFY trial with 64Cu-SAR-bisPSMA PET/CT
SYDNEY, May 29, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with...
Clarity signs high-volume commercial-scale copper-64 Supply Agreement with Nusano
Highlights Clarity has signed a commercial-scale agreement with Nusano, Inc. ("Nusano") for supply of copper-64 (Cu-64 or 64Cu) isotope. The 190,000 square foot Nusano facility in West Valley City, Utah is capable of producing more than 1,000 Ci...